rIX-FP, a recombinant fusion protein linking coagulation factor IX with albumin, demonstrates improved kinetics in cynomolgus monkeys and hemophilia B

被引：0
|
作者：
Nolte, M. W. [1 ]
Nichols, T. C. [2 ]
Muellercohrs, J. [1 ]
Merricks, E. Parker [1 ]
Pragst, I. [1 ]
Zollner, S. [1 ]
Dickneite, G. [1 ]
机构：
[1] CSL Behring GmbH, Marburg, Germany
[2] Univ N Carolina, Francis Owen Blood Res Lab, Dept Pathol & Lab Med, Chapel Hill, NC USA
来源：
HAEMOPHILIA | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：39 / 40
页数：2
相关论文
共 50 条
  • [21] Results of a phase I international clinical trial of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in patients with hemophilia B (PROLONG-9FP)
    Santagostino, E.
    Negrier, C.
    Klamroth, R.
    Tiede, A.
    Pabinger, I.
    Trossaert, M.
    Martinowitz, U.
    Altisent, C.
    Tagliaferri, A.
    Rothschild, C.
    Roman, M. A.
    Lopez-Fernandez, M. F.
    Castaman, G.
    Lambert, T.
    Von Depka-Prondzinski, M.
    Voigt, C.
    Jacobs, I.
    Morfini, M.
    HAEMOPHILIA, 2012, 18 : 22 - 22
  • [22] Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin (rIX-FP) in hemophilia B patients undergoing surgery
    Karim, Faraizah Abdul
    Lepatan, Lynda Mae
    Lienhart, Anne-Marie
    Lopez Fernandez, Maria Fernanda
    Mahlangu, Johnny
    Pabinger, Ingrid
    Li, Yanyan
    Wolko, Denise
    Voigt, Christine
    Jacobs, Iris
    HAEMOPHILIA, 2016, 22 : 44 - 44
  • [23] Efficacy and Safety Results of Prolong-9FP Clinical Program of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B
    Santagostino, Elena
    Voigt, Christine
    Wolko, Denise
    Cole, Grace
    Li, Yanyan
    Jacobs, Iris C.
    BLOOD, 2015, 126 (23)
  • [24] PROLONG-9FP clinical development program - phase I results of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP)
    Santagostino, Elena
    THROMBOSIS RESEARCH, 2013, 131 : S7 - S10
  • [25] Efficacy and safety results of a phase 3 pivotal clinical study of recombinant fusion protein linking coagulation factor IX with albumin (RIX-FP) in previously treated patients with hemophilia B
    Santagostino, E.
    Martinowitz, U.
    Lissitchkov, T.
    Pan-Petesch, B.
    Hanabusa, H.
    Oldenburg, J.
    Boggio, L.
    Negrier, C.
    Pabinger-Fasching, I
    Prondzinski, von Depka M.
    Altisent, C.
    Castaman, G.
    Yamamoto, K.
    Alvarez-Roman, M.
    Voigt, C.
    Jacobs, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 228 - 228
  • [26] Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children Results of a phase 3 trial
    Kenet, Gili
    Chambost, Herve
    Male, Christoph
    Lambert, Thierry
    Halimeh, Susan
    Chernova, Tatiana
    Mancuso, Maria Elisa
    Curtin, Julie
    Voigt, Christine
    Li, Yanyan
    Jacobs, Iris
    Santagostino, Elena
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (04) : 659 - 668
  • [27] Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children with Hemophilia B: Efficacy and Safety from a Phase 3 Pivotal Clinical Trial
    Kenet, G.
    Chambost, H.
    Male, C.
    Lambert, T.
    Alvarez-Roman, M-T
    Halimeh, S.
    Chan, A.
    Barnes, C.
    Chernova, T.
    Blatny, J.
    Mancuso, M. E.
    Meunier, S.
    Komrska, V.
    Laws, H-J
    Morfini, M.
    Curtin, J.
    Blazek, B.
    Voigt, C.
    Jacobs, I.
    Santagostino, E.
    HAEMOPHILIA, 2016, 22 : 22 - 23
  • [28] Efficacy, pharmacokinetics (PK) and safety results of a phase 3 clinical study of recombinant fusion protein linking coagulation factor IX with albumin (RIX-FP) in previously treated children with hemophilia B
    Kenet, G.
    Chambost, H.
    Male, C.
    Lambert, T.
    Alvarez-Roman, M.
    Halimeh, S.
    Chan, A.
    Barnes, C.
    Chernova, T.
    Blatny, J.
    Mancuso, M. E.
    Meunier, S.
    Komrska, V
    Laws, H-J
    Morfini, M.
    Curtain, J.
    Blazek, B.
    Voigt, C.
    Jacobs, I
    Santagostino, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 227 - 228
  • [29] Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program
    Lubetsky, Aaron
    Martinowitz, Uri
    Lissitchkov, Toshko
    Voigt, Christine
    Wolko, Denise
    Jacobs, Iris C.
    Santagostino, Elena
    BLOOD, 2015, 126 (23)
  • [30] Efficacy, PK and safety results of a Phase I/II clinical study of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in previously treated patients with hemophilia B
    Martinowitz, U.
    Lubetsky, A.
    Santagostino, E.
    Jotov, G.
    Brutman-Barazani, T.
    Voigt, C.
    Moises, T.
    Jacobs, I
    Lissitchkov, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 240 - 241
12345